CLASS III Drug recall · Reported 1 Jul 2020 · FDA Enforcement Report

Timolol Maleate USP, 0.5%, Sterile Opthalmic Solution recalled

Rising Pharmaceuticals is recalling Timolol Maleate USP, 0.5%, Sterile Opthalmic Solution, distributed nationwide in the US. The recall was initiated on 15 Nov 2019 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # 089A016, Exp 12/31/2020
NDC64980-513, 64980-514
UPC0364980513050
Quantity recalledN/A

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1367-2020
FDA event ID
85829
Recalling firm
Rising Pharmaceuticals, Saddle Brook, NJ
Manufacturer
Rising Pharma Holdings, Inc.
Classification
Class III
Status
Terminated
Recall initiated
15 Nov 2019
FDA classified
29 Jun 2020
Reported
1 Jul 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility
Drug class
Eye Drops

Timeline

15 Nov 2019Recall initiated by company
29 Jun 2020Classified by FDA+227 days
1 Jul 2020Published in enforcement report+2 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Timolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topical Application in the Eye, Distributed by: Rising Pharmaceuticals, Inc. Saddle Brook, NJ 07663, Manufactured by: FDC Limited B-8, MIDC Industrial Area, Waluj, Aurangbad - 431 136 Marahastra, India, NDC 64980-514-05

Where it was distributed

U.S.A. Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.

Which lots are affected?

Lot # 089A016, Exp 12/31/2020

Where was it sold?

U.S.A. Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 85829
ReportedClassRecallCompanyReasonWhere
CLASS IIITimolol Maleate Sterile Opthalmic Solution recalledTimolol MaleateRising PharmaceuticalsSterilityNationwide

More recalls from Rising Pharmaceuticals

All 9

Other Timolol recalls

All 20
ReportedClassRecallCompanyReasonWhere
DrugCLASS IITimolol Maleate Ophthalmic Solution USP, 0.5%, Sterile recalled by FDCTimolol MaleateFDCOtherNationwide
DrugCLASS IITimolol Maleate Ophthalmic Solution USP, 0.5%, Sterile recalled by FDCTimolol MaleateFDCOtherNationwide
DrugCLASS IITimolol Maleate Ophthalmic Solution USP, 0.5%, Sterile recalled by FDCTimolol MaleateFDCOtherNJ
DrugCLASS IITimolol Maleate Ophthalmic Solution USP, 0.25%, Sterile recalled by FDCTimolol MaleateFDCOtherNJ
DrugCLASS IITimolol Maleate Ophthalmic Solution USP, 0.5%, Sterile recalled by FDCTimolol MaleateFDCOtherNJ